Seminars in Fetal & Neonatal Medicine
Volume 12, Issue 4 , Pages 287-295 , August 2007

Anti-oxidant strategies

  • Giuseppe Buonocore

      Affiliations

    • Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, viale Bracci 36, 53100 Siena, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0577 586 523; fax: +39 0577 586 182.
    • ,
  • Floris Groenendaal

      Affiliations

    • Department of Neonatology, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands

References 

  1. Samuilov VD. Energy problems in life evolution. Biochemistry (Mosc). 2005;70:246–250
  2. Dismukes GC, Klimov VV, Baranov SV, et al. The origin of atmospheric oxygen on Earth: the innovation of oxygenic photosynthesis. Proc Natl Acad Sci USA. 2001;98:2170–2175
  3. Olson JM. Evolution of Photosynthesis (1970), re-examined thirty years later. Photosynth Res. 2001;68:95–112
  4. Blankenship RE. Molecular evidence for the evolution of photosynthesis. Trends Plant Sci. 2001;6:4–6
  5. Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006;141:312–322
  6. Rye R, Holland HD. Paleosols and the evolution of atmospheric oxygen: a critical review. Am J Sci. 1998;298:621–672
  7. Mulkidjanian AY, Koonin EV, Makarova KS, et al. The cyanobacterial genome core and the origin of photosynthesis. Proc Natl Acad Sci USA. 2006;103:13126–13131
  8. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 1995;64:97–112
  9. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rd ed.. Oxford: Oxford University Press/Clarendon Press; 1999;
  10. Fridovich I. Superoxide anion radical (O2−·), superoxide dismutases, and related matters. J Biol Chem. 1997;272:18515–18517
  11. Sutton HC, Winterbourn CC. On the participation of higher oxidation states of iron and copper in Fenton reactions. Free Radic Biol Med. 1989;6:53–60
  12. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep. 1997;17:3–8
  13. Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med. 1999;26:463–471
  14. Liberatori S, Canas B, Tani C, et al. Proteomic approach to the identification of voltage-dependent anion channel protein isoforms in guinea pig brain synaptosomes. Proteomics. 2004;4:1335–1340
  15. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J. 1999;341(Pt 2):233–249
  16. Halestrap AP, McStay GP, Clarke SJ. The permeability transition pore complex: another view. Biochimie. 2002;84:153–166
  17. Taylor DL, Edwards AD, Mehmet H. Oxidative metabolism, apoptosis and perinatal brain injury. Brain Pathol. 1999;9:93–117
  18. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci. 1999;55:1015–1028
  19. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424–C1437
  20. Alvarez B, Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids. 2003;25:295–311
  21. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40
  22. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95
  23. Kovacic P, Jacintho JD. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem. 2001;8:773–796
  24. Ridnour LA, Sim JE, Choi J, et al. Nitric oxide-induced resistance to hydrogen peroxide stress is a glutamate cysteine ligase activity-dependent process. Free Radic Biol Med. 2005;38:1361–1371
  25. Valko M, Morris H, Mazur M, Rapta P, Bilton RF. Oxygen free radical generating mechanisms in the colon: do the semiquinones of vitamin K play a role in the aetiology of colon cancer?. Biochim Biophys Acta. 2001;1527:161–166
  26. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997;82:291–295
  27. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84
  28. Kelly FJ. Free radical disorders of preterm infants. Br Med Bull. 1993;49:668–678
  29. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr. 1996;85:1–4
  30. Frank L, Sosenko IR. Development of lung antioxidant enzyme system in late gestation: possible implications for the prematurely born infant. J Pediatr. 1987;110:9–14
  31. Buonocore G, Perrone S, Bracci R. Free radicals and brain damage in the newborn. Biol Neonate. 2001;79:180–186
  32. Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res. 2000;47:221–224
  33. Buonocore G, Perrone S, Longini M, et al. Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr Res. 2002;52:46–49
  34. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159–163
  35. Kukreja RC, Kontos HA, Hess ML, Ellis EF. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res. 1986;59:612–619
  36. Bracci R, Buonocore G. The antioxidant status of erythrocytes in preterm and term infants. Semin Neonatol. 1998;3:191–197
  37. Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett. 1994;349:197–200
  38. Mishra OP, Delivoria-Papadopoulos M. Cellular mechanisms of hypoxic injury in the developing brain. Brain Res Bull. 1999;48:233–238
  39. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem. 2006;97:1634–1658
  40. Speer CP, Silverman M. Issues relating to children born prematurely. Eur Respir J Suppl. 1998;27:13s–16s
  41. Buonocore G, Zani S, Perrone S, Caciotti B, Bracci R. Intraerythrocyte nonprotein-bound iron and plasma malondialdehyde in the hypoxic newborn. Free Radic Biol Med. 1998;25:766–770
  42. Ciccoli L, Rossi V, Leoncini S, et al. Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns. Free Radic Res. 2003;37:51–58
  43. Warner DS, Sheng H, Batinic-Haberle I. Oxidants, antioxidants and the ischemic brain. J Exp Biol. 2004;207:3221–3231
  44. Larouche A, Roy M, Kadhim H, et al. Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: animal model for perinatally acquired encephalopathy. Dev Neurosci. 2005;27:134–142
  45. Perrone S, Bracci R, Buonocore G. New biomarkers of fetal-neonatal hypoxic stress. Acta Paediatr Suppl. 2002;91:135–138
  46. Bracci R, Buonocore G. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate. 2003;83:85–96
  47. Takagi Y, Nikaido T, Toki T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch. 2004;444:49–55
  48. Buonocore G, Perrone S, Longini M, et al. Non protein bound iron as early predictive marker of neonatal brain damage. Brain. 2003;126:1224–1230
  49. Longini M, Perrone S, Kenanidis A, et al. Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. Free Radic Biol Med. 2005;38:1537–1541
  50. Volpe JJ. Brain injury in the premature infant: neuropathology, clinical aspects and pathogenesis. Ment Retard Dev Disabil Res Rev. 1997;3:3–12
  51. Haynes RL, Folkerth RD, Szweda LI, Volpe JJ, Kinney HC. Lipid peroxidation during human cerebral myelination. J Neuropathol Exp Neurol. 2006;65:894–904
  52. Haynes RL, Baud O, Li J, et al. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol. 2005;15:225–233
  53. Haynes RL, Folkerth RD, Keefe RJ, et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol. 2003;62:441–450
  54. Artlich A, Busch T, Lewandowski K, et al. Exhaled nitric oxide in preterm infants. Respir Physiol. 1998;114:195–200
  55. Aikio O, Pokela ML, Hallman M. Exhaled and nasal nitric oxide in mechanically ventilated preterm and term newborns. Acta Paediatr. 2002;91:1078–1086
  56. Biban P, Zangardi T, Baraldi E, et al. Mixed exhaled nitric oxide and plasma nitrites and nitrates in newborn infants. Life Sci. 2001;68:2789–2797
  57. Ergenekon E, Gucuyener K, Erbas D, Suheyl EF, Atalay Y. Cerebrospinal fluid and serum nitric oxide levels in asphyxiated newborns. Biol Neonate. 1999;76:200–206
  58. Shi Y, Pan F, Li H, et al. Role of carbon monoxide and nitric oxide in newborn infants with postasphyxial hypoxic-ischemic encephalopathy. Pediatrics. 2000;106:1447–1451
  59. Krediet TG, Valk L, Hempenius I, Egberts J, Van Bel F. Nitric oxide production and plasma cyclic guanosine monophosphate in premature infants with respiratory distress syndrome. Biol Neonate. 2002;82:150–154
  60. Farkouh CR, Merrill JD, Ballard PL, et al. Urinary Metabolites of Oxidative Stress and Nitric Oxide in Preterm and Term Infants. Biol Neonate. 2006;90:233–242
  61. Groenendaal F, Lammers H, Smit D, Nikkels PG. Nitrotyrosine in brain tissue of neonates after perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed. 2006;91:F429–F433
  62. Rejdak K, Petzold A, Sharpe MA, et al. Serum and urine nitrate and nitrite are not reliable indicators of intrathecal nitric oxide production in acute brain injury. J Neurol Sci. 2003;208:1–7
  63. Comporti M, Signorini C, Leoncini S, et al. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med. 2004;37:724–732
  64. Dorrepaal CA, Berger HM, Benders MJ, et al. Nonprotein-bound iron in postasphyxial reperfusion injury of the newborn. Pediatrics. 1996;98:883–889
  65. Buonocore G, Zani S, Sargentini I, et al. Hypoxia-induced free iron release in the red cells of newborn infants. Acta Paediatr. 1998;87:77–81
  66. Comporti M, Signorini C, Buonocore G, Ciccoli L. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med. 2002;32:568–576
  67. Ozawa H, Nishida A, Mito T, Takashima S. Development of ferritin-positive cells in cerebrum of human brain. Pediatr Neurol. 1994;10:44–48
  68. Shadid M, Buonocore G, Groenendaal F, et al. Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia. Neurosci Lett. 1998;248:5–8
  69. Peeters-Scholte C, Braun K, Koster J, et al. Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr Res. 2003;54:516–522
  70. Buonocore G, Perrone S, Gioia D, et al. Nucleated red blood cell count at birth as an index of perinatal brain damage. Am J Obstet Gynecol. 1999;181:1500–1505
  71. Buonocore G, Perrone S. Biomarkers of hypoxic brain injury in the neonate. Clin Perinatol. 2004;31:107–116
  72. Saugstad OD, Ramji S, Vento M. Oxygen for newborn resuscitation: how much is enough?. Pediatrics. 2006;118:789–792
  73. Reiter CD, Teng RJ, Beckman JS. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem. 2000;275:32460–32466
  74. Marks KA, Mallard CE, Roberts I, et al. Nitric oxide synthase inhibition attenuates delayed vasodilation and increases injury after cerebral ischemia in fetal sheep. Pediatr Res. 1996;40:185–191
  75. Dorrepaal CA, Shadid M, Steendijk P, et al. Effect of post-hypoxic-ischemic inhibition of nitric oxide synthesis on cerebral blood flow, metabolism and electrocortical brain activity in newborn lambs. Biol Neonate. 1997;72:216–226
  76. Groenendaal F, de Graaf RA, van Vliet G, Nicolay K. Effects of hypoxia-ischemia and inhibition of nitric oxide synthase on cerebral energy metabolism in newborn piglets. Pediatr Res. 1999;45:827–833
  77. van den Tweel ERW, Peeters-Scholte CMPCD, Van Bel F, Heijnen CJ, Groenendaal F. Inhibition of nNOS and iNOS following hypoxia-ischemia improves long-term outcome but does not influence the inflammatory response in the neonatal rat brain. Dev Neurosci. 2002;24:389–395
  78. Higuchi Y, Hattori H, Kume T, et al. Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine. Eur J Pharmacol. 1998;342:47–49
  79. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab. 2005;25:502–512
  80. Park EM, Cho S, Frys KA, et al. Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury. J Cereb Blood Flow Metab. 2006;26:392–401
  81. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663–670
  82. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574–1584
  83. Levene MI, Kornberg J, Williams THC. The incidence and severity of postasphyxial encephalopathy in full-term infants. Early Hum Dev. 1985;11:21–28
  84. Hull J, Dodd KL. Falling incidence of hypoxic-ischaemic encephalopathy in term infants. Br J Obstet Gynaecol. 1992;99:386–391
  85. Thornberg E, Thiringer K, Odeback A, Milsom I. Birth asphyxia: incidence, clinical course and outcome in a Swedish population. Acta Paediatr. 1995;84:927–932
  86. Smith J, Wells L, Dodd K. The continuing fall in incidence of hypoxic-ischaemic encephalopathy in term infants. Br J Obstet Gynaecol. 2000;107:461–466
  87. MacDonald HM, Mulligan JC, Allen AC, Taylor PM. Neonatal asphyxia. I. Relationship of obstetric and neonatal complications to neonatal mortality in 38,405 consecutive deliveries. J Pediatr. 1980;96:898–902
  88. Saugstad OD. Oxidative stress in the newborn–a 30-year perspective. Biol Neonate. 2005;88:228–236
  89. Peeters C, van Bel F. Pharmacotherapeutical reduction of post-hypoxic-ischemic brain injury in the newborn. Biol Neonate. 2001;79:274–280
  90. Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev. 2002;[CD000501]
  91. Watts JL, Milner R, Zipursky A, et al. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight. Eur Respir J. 1991;4:188–190
  92. Liu XH, Kato H, Araki T, et al. An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase following focal cerebral ischemia in the rat. Brain Res. 1994;644:257–266
  93. Armstead WM, Mirro R, Thelin OP, et al. Polyethylene glycol superoxide dismutase and catalase attenuate increased blood-brain barrier permeability after ischemia in piglets. Stroke. 1992;23:755–762
  94. Davis JM, Parad RB, Michele T, et al. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics. 2003;111:469–476
  95. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593–597
  96. Ahola T, Lapatto R, Raivio KO, et al. N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial. J Pediatr. 2003;143:713–719
  97. Darlow BA, Buss H, McGill F, et al. Vitamin C supplementation in very preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2005;90:F117–22.
  98. Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2003;[CD003665]
  99. Palmer C, Towfighi J, Roberts RL, Heitjan DF. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res. 1993;33:405–411
  100. Van Bel F, Shadid M, Moison RMW, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics. 1998;101:185–193
  101. Benders MJ, Bos AF, Rademaker CM, et al. Early postnatal allopurinol does not improve short-term outcome after severe birth asphyxia. Arch Dis Child Fetal Neonatal Ed. 2006;91:F163–F165
  102. van Kesteren C, Benders MJ, Groenendaal F, et al. Population pharmacokinetics of allopurinol in full-term neonates with perinatal asphyxia. Ther Drug Monit. 2006;28:339–344
  103. Clancy RR, McGaurn SA, Goin JE, et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics. 2001;108:61–70
  104. Poeggeler B, Saarela S, Reiter RJ, et al. Melatonin–a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann NY Acad Sci. 1994;738:419–420
  105. Tutunculer F, Eskiocak S, Basaran UN, et al. The protective role of melatonin in experimental hypoxic brain damage. Pediatr Int. 2005;47:434–439
  106. Gitto E, Reiter RJ, Cordaro SP, et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol. 2004;21:209–216
  107. Gitto E, Reiter RJ, Amodio A, et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res. 2004;36:250–255

PII: S1744-165X(07)00021-2

doi: 10.1016/j.siny.2007.01.020

Seminars in Fetal & Neonatal Medicine
Volume 12, Issue 4 , Pages 287-295 , August 2007

Article Tools

* Image Usage & Resolution